Breast Cancer Brachytherapy Market, By Technology (High Dose Rate (HDR) Brachytherapy and Low Dose Rate (LDR) Brachytherapy), By Application (Early Stage Breast Cancer, Recurring Breast Cancer, and Others), By End User (Hospitals, Oncology Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

The global breast cancer brachytherapy market is estimated to be valued at USD 961.1 Mn in 2025 and is expected to reach USD 1,544.3 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.0% from 2025 to 2032. Breast cancer brachytherapy is a form of radiation therapy that involves placing radioactive seeds... View more

Brachytherapy Market, By Product Type (Permanent Brachytherapy, High-Dose-Rate (HDR), Low-Dose-Rate (LDR), Pulsed-Dose-Rate (PDR), Electronic Brachytherapy, Others), By Application (Prostate Cancer, Breast Cancer, Gynaecological Cancer, Others), By End-user (Hospitals, Ambulatory Surgical Centers, Cancer Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Brachytherapy Market Size and Forecast – 2025 – 2032 The Global Brachytherapy Market size is estimated to be valued at USD 1.6 billion in 2025 and is expected to reach USD 2.7 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032. Overview ... View more

Brachytherapy Afterloaders Market, by Technique (Low Dose Rate (LDR) Afterloader and High Dose Rate (HDR) Afterloader), by Application (Prostate Cancer, Breast Cancer, Cervical Cancer, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

Brachytherapy is type of radiotherapy in which a closed radiation source is positioned directly into or next to area that requires treatment. It is used to cure cancer tissues at specific sites and is frequently used as an effective treatment for breast, cervical, skin, and prostate cancer... View more